Venclexta (Venetoclax) | Alleviare Life Sciences

To treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

·         Azacitidine, or decitabine, or in combination with low-dose cytarabine for the treatment of adults with newly diagnosed acute myeloid leukemia (AML):

o   are 75 years of age or older, or

o   There are other medical conditions that preclude the use of standard chemotherapy.

It is not known whether VENCLEXTA is safe and effective in children.



Important Safety Information

What is the most important information I should know about Venclexta?

VENCLEXTA can cause serious side effects, including:

Tumor lysis syndrome (TLS). TLS is caused by the rapid breakdown of cancer cells. TLS can lead to kidney failure, the need for dialysis treatment, and death. Your healthcare provider will perform tests to check your risk of getting TLS before you start taking Venclexta. You will receive other medicines before and during treatment with Venclexta to help reduce your risk of TLS.

You may also need to receive intravenous (IV) fluids into your vein. your healthcare provider will

Blood tests to check for TLS when you first start treatment and during treatment with Venclexta.

It is important to keep your appointments for blood tests. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with VENCLEXTA, including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual Fatigue is involved or muscle or joint pain.

Drink plenty of water during treatment with Venclexta to help reduce your risk of getting TLS. Drink 6 to 8 glasses (56 ounces total) of water each day, starting 2 days before your first dose.

On the day of your first dose of VENCLEXTA, and each time your dose is increased.

Your healthcare provider may delay, reduce your dose, or stop treatment with VENCLEXTA if side effects occur. When restarting VENCLEXTA after stopping for 1 week or longer, your healthcare provider may check your risk of TLS again and change your dose.

Location: New Delhi, Delhi, India

Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·          fast weight gain (greater than 10 pounds within a week) ·          bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m
Read more

Hunter Syndrome is Very Rare | Named Patient Program in India

Image
  Hunter Syndrome is an extremely uncommon, acquired hereditary problem brought about by an absent or breaking down compound. In Hunter disorder, the body needs more of the compound iduronate 2-sulfatase. This present compound's responsibility is to separate specific complex particles, and without enough of this protein, the atoms develop in unsafe sums.  The development of enormous measures of these unsafe substances in the long run causes long-lasting, moderate harm influencing appearance, mental turn of events, organ work and actual capacities. Hunter Syndrome is undeniably more normal in young men. The condition is one kind of a gathering of acquired metabolic issues called mucopolysaccharidoses (MPSs). Tracker condition is otherwise called MPS II. Import Elaprase (idursulfase) medicine under named patient program which is commonly use for hunter syndrome.  There's no remedy for Hunter disorder. Treatment includes overseeing side effects and difficulties. Side effects Syndr
Read more

Glyxambi (empagliflozin and linagliptin) Medicine - Uses, Precautions, Indications

Image
What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy
Read more